Medicine Information

Ephedra Product Ban


Ephedra is a naturally occuring herbal dietary supplement that has been marketed as a weight loss drug. The principal active ingredient is an amphetamine-like compound. Because it has been marketed as an herbal supplement and not a drug, you may not have considered talking to your doctor about it, but if you have been using Ephedra or any dietary supplement containing ephedrine alkaloids, such as ephedra, ma huang, Sida cordifolia, and pinellia, stop immediately and consult a doctor! The FDA has advised consumers to stop using these dietary supplements and published a final ruling in 2004 to ban the sale of all supplements containing ephedrine alkaloids.

After reviewing Ephedra, the Food and Drug Administration found that it has little positive effects beyond temporary short-term weight loss. To the contrary, Ephedra raises blood pressure and stresses the heart. Many people using Ephedra to lose weight have suffered strokes and died. Recent studies have confirmed that Ephedra use raises blood pressure and stresses the circulatory system. Furthermore, a study of calls to poison control centers revealed that a disproportionate rate of negative reactions were cased by Ephedra as opposed to other herbal products.

If you are using ephedra or ma huang, discontinue use immediately. If you used ephedra in the past and are now experience symptoms of high blood pressure, intense headaches, or heart palpitations, contact a lawyer right away to discuss your case.

To find out why you need an Ephedra lawyer and read articles about dangerous drugs and Ephedra side effects, visit our website at hugesettlements.com.

If you have any questions or concerns about filing a Ephedra lawsuit, please contact a professional Ephedra attorney right away!


MORE RESOURCES:

Warning: fopen(http://news.google.com/news?sourceid=navclient&ie=UTF-8&rls=GGLG,GGLG:2005-22,GGLG:en&q=Medicine&output=rss) [function.fopen]: failed to open stream: Network is unreachable in /srv/disk1/medicineinfo/www/medicineinfo.awardspace.com/inc/rss.inc on line 81
could not open XML input